Latest News
September 26, 2023 | Magnify incubator company, Partillion Bioscience announces financing and partnership
The Magnify incubator at the California NanoSystems Institute at UCLA is celebrating the growth of one of its companies. Partillion Bioscience is a venture-backed life science company commercializing Nanovials, a next generation single-cell analysis platform....
August 14, 2023 | New study identifies genes linked to high production of key antibody
A collaboration led by UCLA and the Seattle Children’s Research Institute has yielded new knowledge about the genes responsible for the production and release of immunoglobulin G, the most common type of antibody in the human body. The finding has the potential to...
July 6, 2023 | An exceptional partnership: How CNSI’s Magnify Internship Program is helping UCLA students “Thrive”
Last year funding from the state of California was provided to the California Institutes for Science& Innovation, including the California NanoSystems Institute at UCLA, known at CNSI, to create workforce development programs focused on providing necessary...
Co-op Researcher 2 – Regeneron
The Peptide Discovery Group at Regeneron, based in Los Angeles, is focused on identifying cyclic peptide binders against therapeutic proteins of interest. This Co-op researcher will be trained in standard peptide synthetic techniques and medicinal chemistry to synthesize and optimize lead compounds for approved research programs and targets.
Co-op Researcher 1 – Regeneron
The Peptide Discovery Group at Regeneron, based in Los Angeles, is focused on identifying cyclic peptide binders against therapeutic proteins of interest. We are looking for a researcher to support the screening and lead characterization efforts. They will be responsible for conducting screens to discover cyclic peptide ligands. They will also perform biological assays to profile peptide performance.
June 13, 2023 | UCLA Computer Scientist Receives Major International Semiconductor Award
A member of the UCLA faculty since 1990, Cong was selected to receive the award at the May 8 event in Tel Aviv for his groundbreaking research and development that “revolutionized electronic design automation and FPGA [field-programmable gate array] design methods, for co-founding several chip design related companies, and for teaching hundreds of UCLA students, many of them who now hold influential roles in the semiconductor industry.”
June 12, 2023 | Ready, Set … Accelerate!
UCLA has a long history of nurturing business prospects generated by both students and faculty. But the rise of the incubators is a more engineered process. It was sparked in 2007, when Chancellor Gene Block and Governor Gray Davis agreed to promote closer links between UCLA and the private sector. The first incubators were small and isolated; today, they are model workplaces that “talk” to one another. World-builders whose business blueprints pass scrutiny by a professional board can start their journey at one incubator and finish at another.
Research Scientist – Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a privately funded biotech company, advancing a pipeline of single domain antibody drugs into the clinic. Sorriso’s preclinical and clinical pipeline focuses on local delivery of these therapeutics to treat human autoimmune diseases…
May 11, 2023 | When stem cells can’t roll on a bumpy road, muscles break down
In a study recently published in npj Regenerative Medicine, a group of researchers led by biochemists at UCLA show for the first time that scarring to the collagen framework that carries these healing cells causes muscles to gradually stop working in Duchenne muscular...